3762
J.-H. Chu et al.
PAPER
(CH), 130.7 (CH), 135.8 (CH × 2), 138.2 (Cq), 139.7 (Cq), 143.1
(Cq), 148.1 (Cq), 149.6 (CH), 158.6 (Cq).
(CH × 2), 132.8 (Cq), 135.5 (CH), 139.3 (Cq), 139.5 (Cq), 139.8
(Cq), 149.5 (CH), 159.0 (Cq).
MS (EI, 70 eV): m/z (%) = 276 (22) [M+], 275 (64) [M – H+], 229
MS (EI, 70 eV): m/z (%) = 266 (4) [M+ + 1], 264 (11) [M+ – 1], 84
(100), 202 (21), 84 (23).
(100), 47 (22).
HRMS (EI): m/z [M]+ calcd for C17H12N2O2: 276.0899; found:
HRMS (EI): m/z [M]+ calcd for C17H1235ClN: 265.0658; found:
276.0894.
265.0653.
2-(4¢-Methoxybiphenyl-2-yl)pyridine (3d)3b
Colorless viscous liquid; Rf = 0.72 (n-hexane–EtOAc, 5:2).
2-(4¢-Bromobiphenyl-2-yl)pyridine (3h)
Colorless viscous liquid; Rf = 0.69 (n-hexane–EtOAc, 5:2).
1H NMR (400 MHz, CDCl3): d = 3.78 (s, 3 H), 6.77 (d, J = 8.8 Hz,
2 H), 6.90 (d, J = 8.0 Hz, 1 H), 7.07 (d, J = 8.8 Hz, 2 H), 7.10 (ddd,
J = 7.5, 5.0, 1.2 Hz, 1 H), 7.38–7.45 (m, 4 H), 7.66–7.68 (m, 1 H),
8.64 (ddd, J = 5.0, 1.8, 1.0 Hz, 1 H).
1H NMR (400 MHz, CDCl3): d = 6.92 (dt, J = 8.2, 1.2 Hz, 1 H),
7.02 (d, J = 6.8 Hz, 2 H), 7.13 (ddd, J = 7.3, 1.2 Hz, 1 H), 7.36 (d,
J = 8.2 Hz, 2 H), 7.39–7.49 (m, 4 H), 7.66–7.68 (m, 1 H), 8.62 (ddd,
J = 4.8, 1.8, 1.2 Hz, 1 H).
13C NMR (100 MHz, CDCl3): d = 55.2 (CH3), 113.5 (CH × 2),
121.3 (CH), 125.4 (CH), 127.3 (CH), 128.5 (CH), 130.4 (CH),
130.5 (CH), 130.8 (CH × 2), 133.7 (Cq), 135.2 (CH), 139.4 (Cq),
140.2 (Cq), 149.4 (CH), 158.5 (Cq), 159.5 (Cq).
13C NMR (100 MHz, CDCl3): d = 121.0 (Cq), 121.5 (CH), 125.2
(CH), 128.0 (CH), 128.6 (CH), 130.3 (CH), 130.6 (CH), 131.2
(CH × 2), 131.3 (CH × 2), 135.5 (CH), 139.3 (Cq), 139.4 (Cq), 140.3
(Cq), 149.5 (CH), 159.0 (Cq).
MS (EI, 70 eV): m/z (%) = 261 (14) [M+], 217 (14), 84 (100), 47
MS (EI, 70 eV): m/z (%) = 310 (24) [M+], 308 (23) [M+ – 2], 84
(26).
(100), 47 (35).
HRMS (EI): m/z [M]+ calcd for C18H15NO: 261.1154; found:
HRMS (EI): m/z [M]+ calcd for C17H12BrN: 309.0153; found:
261.1154.
309.0152.
2-(4¢-tert-Butylbiphenyl-2-yl)pyridine (3e)
Colorless viscous liquid; Rf = 0.72 (n-hexane–EtOAc, 5:2).
2-(4¢-Iodobiphenyl-2-yl)pyridine (3i)
Colorless viscous liquid; Rf = 0.69 (n-hexane–EtOAc, 5:2).
1H NMR (400 MHz, CDCl3): d = 1.29 (s, 9 H), 6.89 (d, J = 8.0 Hz,
1 H), 7.08 (d, J = 8.8 Hz, 2 H), 7.11 (ddd, J = 6.6 Hz, 1 H), 7.23–
7.26 (m, 3 H), 7.37 (td, J = 8.0, 1.6 Hz, 1 H), 7.43–7.45 (m, 2 H),
7.68–7.70 (m, 1 H), 8.64 (ddd, J = 5.0, 1.8, 1.2 Hz, 1 H).
1H NMR (400 MHz, CDCl3): d = 6.89 (d, J = 8.4 Hz, 2 H), 6.93 (d,
J = 8.0 Hz, 1 H), 7.14 (ddd, J = 7.3, 4.9, 1.2 Hz, 1 H), 7.38–7.41 (m,
1 H), 7.44–7.50 (m, 3 H), 7.56 (d, J = 8.4 Hz, 2 H), 7.66–7.68 (m, 1
H), 8.62 (ddd, J = 4.9, 1.8, 1.2 Hz, 1 H).
13C NMR (100 MHz, CDCl3): d = 31.3 (CH3), 34.4 (Cq), 121.3
(CH), 124.9 (CH × 2), 125.5 (CH), 127.4 (CH), 128.5 (CH), 129.3
(CH × 2), 130.5 (CH × 2), 135.1 (CH), 138.2 (Cq), 139.4 (Cq), 140.5
(Cq), 149.4 (CH), 149.6 (Cq), 159.4 (Cq).
13C NMR (100 MHz, CDCl3): d = 92.6 (Cq), 121.5 (CH), 125.3
(CH), 128.0 (CH), 128.7 (CH), 130.2 (CH), 130.6 (CH), 131.5
(CH × 2), 135.5 (CH), 137.2 (CH × 2), 139.4 (Cq × 2), 140.9 (Cq),
149.5 (CH), 159.0 (Cq).
MS (EI, 70 eV): m/z (%) = 287 (50) [M+], 286 (100) [M – H+], 272
MS (EI, 70 eV): m/z (%) = 357 (39) [M+], 356 (100) [M – H+], 228
(27), 84 (67).
(53), 84 (68).
HRMS (EI): m/z [M]+ calcd for C21H21N: 287.1674; found:
HRMS (EI): m/z [M]+ calcd for C17H12IN: 357.0014; found:
287.1676.
357.0014.
2-(4¢-Fluorobiphenyl-2-yl)pyridine (3f)1i
Colorless viscous liquid; Rf = 0.69 (n-hexane–EtOAc, 5:2).
5¢-Methyl-2¢-(2-pyridyl)biphenyl-4-carbaldehyde (6a)
Colorless viscous liquid; Rf = 0.47 (n-hexane–EtOAc, 5:2).
1H NMR (400 MHz, CDCl3): d = 6.88–6.95 (m, 3 H), 7.09–7.13 (m,
3 H), 7.39–7.48 (m, 4 H), 7.66–7.68 (m, 1 H), 8.63 (ddd, J = 5.0,
1.8, 1.0 Hz, 1 H).
1H NMR (400 MHz, CDCl3): d = 2.46 (s, 3 H), 6.92 (dt, J = 8.0, 1.2
Hz, 1 H), 7.12 (ddd, J = 7.4, 4.8, 1.2 Hz, 1 H), 7.30–7.35 (m, 4 H),
7.43 (td, J = 8.2, 1.6 Hz, 1 H), 7.60 (d, J = 7.6 Hz, 1 H), 7.75 (d,
J = 8.4 Hz, 2 H), 8.58 (ddd, J = 4.8, 1.8, 1.2 Hz, 1 H), 9.98 (s, 1 H).
13C NMR (100 MHz, CDCl3): d = 21.2 (CH3), 121.5 (CH), 125.2
(CH), 129.2 (CH), 129.5 (CH × 2), 130.3 (CH × 2), 130.6 (CH),
131.0 (CH), 134.6 (Cq), 135.6 (CH), 136.8 (Cq), 138.6 (Cq), 139.2
(Cq), 148.1 (Cq), 149.4 (CH), 158.8 (Cq), 192.0 (CH).
13C NMR (100 MHz, CDCl3): d = 115.0 (d, JC-F = 20.0 Hz, CH × 2),
121.4 (CH), 125.3 (CH), 127.8 (CH), 128.6 (CH), 130.4 (d, JC-F
=
12.1 Hz, CH × 2), 131.1 (CH), 131.2 (CH), 135.4 (CH), 137.3 (d,
JC-F = 3.8 Hz, Cq), 139.5 (Cq × 2), 149.5 (CH), 159.1 (Cq), 161.9 (d,
JC-F = 240.0 Hz, Cq).
MS (EI, 70 eV): m/z (%) = 249 (14) [M+], 248 (43) [M – H+], 84
MS (EI, 70 eV): m/z (%) = 273 (40) [M+], 272 (100) [M – H+], 84
(100), 47 (26).
(53).
HRMS (EI): m/z [M]+ calcd for C17H12FN: 249.0954; found:
HRMS (EI): m/z [M]+ calcd for C19H15NO: 273.1154; found:
249.0954.
273.1154.
2-(4¢-Chlorobiphenyl-2-yl)pyridine (3g)
Colorless viscous liquid; Rf = 0.69 (n-hexane–EtOAc, 5:2)
6-(2-Pyridyl)biphenyl-3,4¢-dicarbaldehyde (6b)
Colorless viscous liquid; Rf = 0.25 (n-hexane–EtOAc, 5:2)
1H NMR (400 MHz, CDCl3): d = 6.92 (dt, J = 8.0, 1.2 Hz, 1 H),
7.08 (d, J = 8.6 Hz, 2 H), 7.13 (ddd, J = 7.5, 4.8, 1.2 Hz, 1 H), 7.21
(d, J = 8.6 Hz, 2 H), 7.39–7.50 (m, 4 H), 7.66–7.69 (m, 1 H), 8.62
(ddd, J = 5.0, 1.8, 1.2 Hz, 1 H).
13C NMR (100 MHz, CDCl3): d = 121.5 (CH), 125.2 (CH), 127.9
(CH), 128.3 (CH × 2), 128.6 (CH), 130.3 (CH), 130.6 (CH), 130.9
1H NMR (400 MHz, CDCl3): d = 6.98 (d, J = 7.6 Hz, 1 H), 7.20
(ddd, J = 7.5, 4.9, 1.2 Hz, 1 H), 7.35 (d, J = 8.0 Hz, 2 H), 7.49 (td,
J = 7.8, 1.6 Hz, 1 H), 7.79 (d, J = 8.0 Hz, 2 H), 7.90 (d, J = 7.6 Hz,
1 H), 7.98 (d, J = 1.6 Hz, 1 H), 8.03 (dd, J = 7.6, 1.6 Hz, 1 H), 8.64
(ddd, J = 4.8, 1.6, 0.8 Hz, 1 H), 10.00 (s, 1 H), 10.14 (s, 1 H).
13C NMR (100 MHz, CDCl3): d = 122.5 (CH), 125.1 (CH), 129.5
(CH), 129.7 (CH × 2), 130.2 (CH × 2), 131.4 (CH), 131.6 (CH),
Synthesis 2009, No. 22, 3757–3764 © Thieme Stuttgart · New York